Yarbrough Capital’s Rentokil RTO Stock Holding History

Yarbrough Capital’s Portfolio RTO Stock Details RTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,610	Closed	-$327K	–	233
2022 Q4	$327K	Buy	+10,610	New	+$329K	0.03%	136

Other funds holding RTO

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

GCM

Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

MIG Capital Newport Beach, California $589M AUM 25.96% 1-Year Est. Return

Yarbrough Capital's RTO Position: Q1 2023 in Review

Yarbrough Capital sold out of Rentokil (RTO) in Q1 2023, closing a stake of 10,610 shares — an estimated $327K sold.

Yarbrough Capital first reported a position in RTO in Q4 2022 and held it in 1 quarter. The position peaked at $327K in Q4 2022. 191 funds tracked by Wall St. Rank hold RTO as of Q1 2023.

Yarbrough Capital reported no remaining Rentokil position as of Q1 2023 after selling out during the quarter.
Yarbrough Capital sold 10,610 Rentokil shares in Q1 2023, an estimated $327K.
Yarbrough Capital first reported a position in Rentokil in Q4 2022 and held it in 1 quarter.
Yarbrough Capital's Rentokil position peaked at $327K in Q4 2022.
191 funds tracked by Wall St. Rank held Rentokil as of Q1 2023.

Based on Yarbrough Capital's 13F filing for Q1 2023, filed 13 Apr 2023.